Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↓ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ | Debt to equity ↓ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CADLCandel Therapeutics, Inc. | 2022 | 47 | $748.4M | $9.78 | -1.61% | — | -55.47% | — | -15,035.20% | 1 | 0.04 |